Amarin Corp Plcuk (AMRN) Shareholder's Equity Growth (5y) (2015 - 2026)

Amarin Corp Plcuk (AMRN) Shareholder's Equity Growth (5y) (2015 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.67%
Dec 31, 2025 -6.05%
Sep 30, 2025 -5.45%
Jun 30, 2025 -5.06%
Mar 31, 2025 -4.16%
Dec 31, 2024 -4.38%
Sep 30, 2024 -2.27%
Jun 30, 2024 29.92%
Mar 31, 2024 31.12%
Dec 31, 2023 29.37%
Sep 30, 2023 65.65%
Jun 30, 2023 69.98%
Mar 31, 2023 106.01%
Dec 31, 2022 61.96%
Sep 30, 2022 71.30%
Jun 30, 2022 76.16%
Mar 31, 2022 89.26%
Dec 31, 2021 137.55%
Sep 30, 2021 111.51%
Jun 30, 2021 42.74%